BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

571 related articles for article (PubMed ID: 11293648)

  • 1. The myocardial Na+/H+ exchanger: a potential therapeutic target for the prevention of myocardial ischaemic and reperfusion injury and attenuation of postinfarction heart failure.
    Karmazyn M; Sostaric JV; Gan XT
    Drugs; 2001; 61(3):375-89. PubMed ID: 11293648
    [TBL] [Abstract][Full Text] [Related]  

  • 2. NHE-1 inhibition: from protection during acute ischaemia/reperfusion to prevention/reversal of myocardial remodelling.
    Linz WJ; Busch AE
    Naunyn Schmiedebergs Arch Pharmacol; 2003 Oct; 368(4):239-46. PubMed ID: 14504689
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sodium ion/hydrogen ion exchange inhibition: a new pharmacologic approach to myocardial ischemia and reperfusion injury.
    Levitsky J; Gurell D; Frishman WH
    J Clin Pharmacol; 1998 Oct; 38(10):887-97. PubMed ID: 9807968
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mechanisms of protection of the ischemic and reperfused myocardium by sodium-hydrogen exchange inhibition.
    Karmazyn M
    J Thromb Thrombolysis; 1999 Jul; 8(1):33-8. PubMed ID: 10481212
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The myocardial sodium-hydrogen exchanger (NHE) and its role in mediating ischemic and reperfusion injury.
    Karmazyn M
    Keio J Med; 1998 Jun; 47(2):65-72. PubMed ID: 9659815
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of the myocardial sodium-hydrogen exchanger in mediating ischemic and reperfusion injury. From amiloride to cariporide.
    Karmazyn M
    Ann N Y Acad Sci; 1999 Jun; 874():326-34. PubMed ID: 10415544
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The cardiac Na-H exchanger: a key downstream mediator for the cellular hypertrophic effects of paracrine, autocrine and hormonal factors.
    Fliegel L; Karmazyn M
    Biochem Cell Biol; 2004 Dec; 82(6):626-35. PubMed ID: 15674430
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Basic biology and pharmacology of the cardiac sarcolemmal sodium/hydrogen exchanger.
    Avkiran M
    J Card Surg; 2003; 18 Suppl 1():3-12. PubMed ID: 12691374
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The sodium-hydrogen exchange system in the heart: its role in ischemic and reperfusion injury and therapeutic implications.
    Karmazyn M
    Can J Cardiol; 1996 Oct; 12(10):1074-82. PubMed ID: 9191501
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeting the myocardial sodium-hydrogen exchange for treatment of heart failure.
    Morris K
    Expert Opin Ther Targets; 2002 Jun; 6(3):291-8. PubMed ID: 12223070
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rational basis for use of sodium-hydrogen exchange inhibitors in myocardial ischemia.
    Avkiran M
    Am J Cardiol; 1999 May; 83(10A):10G-17G; discussion 17G-18G. PubMed ID: 10482175
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The myocardial Na(+)-H(+) exchange: structure, regulation, and its role in heart disease.
    Karmazyn M; Gan XT; Humphreys RA; Yoshida H; Kusumoto K
    Circ Res; 1999 Oct; 85(9):777-86. PubMed ID: 10532945
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Blocking Na(+)-H+ exchange by cariporide reduces Na(+)-overload in ischemia and is cardioprotective.
    Hartmann M; Decking UK
    J Mol Cell Cardiol; 1999 Nov; 31(11):1985-95. PubMed ID: 10591025
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects and interaction, of cariporide and preconditioning on cardiac arrhythmias and infarction in rat in vivo.
    Aye NN; Komori S; Hashimoto K
    Br J Pharmacol; 1999 Jun; 127(4):1048-55. PubMed ID: 10433514
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Na+/H+ exchange inhibitors for ischemic diseases].
    Hashimoto K
    Nihon Yakurigaku Zasshi; 2001 Dec; 118(6):363-70. PubMed ID: 11778453
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Na+/H+ exchange inhibitors: a new class of cardioprotectors].
    Pisarenko OI
    Ross Fiziol Zh Im I M Sechenova; 2004 Sep; 90(9):1103-12. PubMed ID: 15559784
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intracellular sodium hydrogen exchange inhibition and clinical myocardial protection.
    Mentzer RM; Lasley RD; Jessel A; Karmazyn M
    Ann Thorac Surg; 2003 Feb; 75(2):S700-8. PubMed ID: 12607715
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Therapeutic potential of Na-H exchange inhibitors for the treatment of heart failure.
    Karmazyn M
    Expert Opin Investig Drugs; 2001 May; 10(5):835-43. PubMed ID: 11322861
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sarcolemmal Na+/H+ exchanger activity and expression in human ventricular myocardium.
    Yokoyama H; Gunasegaram S; Harding SE; Avkiran M
    J Am Coll Cardiol; 2000 Aug; 36(2):534-40. PubMed ID: 10933369
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of nitric oxide and free radicals in cardioprotection by blocking Na+/H+ and Na+/Ca2+ exchange in rat heart.
    Maczewski M; Beresewicz A
    Eur J Pharmacol; 2003 Feb; 461(2-3):139-47. PubMed ID: 12586209
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.